Medelis competitorsClear all
Medelis's top competitors include ImmunoGen, Aeglea Biotherapeutics, XBiotech and ProQinase.
| Save Comparison |  Medelis Medelis is a specialty oncology contract research organization focused on preclinical and phase 1 through phase 3 oncology trials. |  ImmunoGen ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology. |  Aeglea Biotherapeutics Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer. | ||
Founding Date | Founding Date 2003 | Founding Date 1981 | Founding Date 2013 | Founding Date 2005 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Nashville, US HQ | Locations Waltham, US HQ Brentwood, US | Locations Austin, US HQ Austin, US | Locations Austin, US HQ | Locations Freiburg im Breisgau, DE HQ |
Employees | Employees 28 | Employees 7575% decrease | Employees 761% increase | Employees 603% increase | Employees 20 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 356.7 m | Valuation ($) 496 m | Valuation ($) N/A |
Twitter followers | Twitter followers 1.6 k | Twitter followers 914 | Twitter followers N/A | Twitter followers 261 | Twitter followers 83 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 0.1 | Average likes per tweet (last 30 days) 6 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 10% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 198850 | Alexa Website Rank 317275 | Alexa Website Rank 401753 | Alexa Website Rank 267939 | Alexa Website Rank 372752 |
Employee Rating | Employee Rating 1.2 | Employee Rating 2.8 | Employee Rating 4.3 | Employee Rating 3 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.3m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($104.1m) (FY, 2019) | Net income ($78.3m) (FY, 2019) | Net income $668.6m (FY, 2019) | Net income N/A |
For sources of this data, please see the company profile
View company profiles
ImmunoGen
HQ
Waltham, US
Employees
75
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
View companyAeglea Biotherapeutics
HQ
Austin, US
Employees
76↑ 1% increase
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
View company
XBiotech
HQ
Austin, US
Employees
60↑ 3% increase
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
View company
ProQinase
HQ
Freiburg im Breisgau, DE
ProQinase is a contract research organization for drug discovery in oncology.
View company